Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Curent Deferred Tax Liability: 2012-2015

Historic Curent Deferred Tax Liability for Ligand Pharmaceuticals (LGND) over the last 2 years, with Mar 2015 value amounting to $258,000.

  • Ligand Pharmaceuticals' Curent Deferred Tax Liability fell 83.61% to $258,000 in Q1 2015 from the same period last year, while for Mar 2015 it was $258,000, marking a year-over-year decrease of 83.61%. This contributed to the annual value of $257,000 for FY2014, which is 83.67% down from last year.
  • As of Q1 2015, Ligand Pharmaceuticals' Curent Deferred Tax Liability stood at $258,000, which was up 0.39% from $257,000 recorded in Q4 2014.
  • Ligand Pharmaceuticals' Curent Deferred Tax Liability's 5-year high stood at $1.6 million during Q4 2012, with a 5-year trough of $257,000 in Q4 2014.
  • In the last 3 years, Ligand Pharmaceuticals' Curent Deferred Tax Liability had a median value of $1.6 million in 2014 and averaged $1.3 million.
  • Data for Ligand Pharmaceuticals' Curent Deferred Tax Liability shows a maximum YoY plummeted of 83.67% (in 2014) over the last 5 years.
  • Quarterly analysis of 4 years shows Ligand Pharmaceuticals' Curent Deferred Tax Liability stood at $1.6 million in 2012, then declined by 0.44% to $1.6 million in 2013, then slumped by 83.67% to $257,000 in 2014, then crashed by 83.61% to $258,000 in 2015.
  • Its Curent Deferred Tax Liability was $258,000 in Q1 2015, compared to $257,000 in Q4 2014 and $1.6 million in Q3 2014.